Clinical Trial Update: A Study of the SMART Stent in the Treatment SFA Disease. [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the SMART Stent for superficial femoral artery disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Artery Disease

Drugs mentioned

• SMART Stent

Snippet

Sponsor: Cordis US Corp. | Conditions: Peripheral Artery Disease | Phase 2 | Status: COMPLETED